SE7502995L - - Google Patents

Info

Publication number
SE7502995L
SE7502995L SE7502995A SE7502995A SE7502995L SE 7502995 L SE7502995 L SE 7502995L SE 7502995 A SE7502995 A SE 7502995A SE 7502995 A SE7502995 A SE 7502995A SE 7502995 L SE7502995 L SE 7502995L
Authority
SE
Sweden
Application number
SE7502995A
Inventor
J T Witkowski
R K Robins
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/452,065 external-priority patent/US3984396A/en
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Publication of SE7502995L publication Critical patent/SE7502995L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE7502995A 1974-03-18 1975-03-17 SE7502995L (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/452,065 US3984396A (en) 1971-06-01 1974-03-18 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters

Publications (1)

Publication Number Publication Date
SE7502995L true SE7502995L (xx) 1975-09-19

Family

ID=23794869

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7502995A SE7502995L (xx) 1974-03-18 1975-03-17

Country Status (13)

Country Link
JP (1) JPS50154253A (xx)
AR (1) AR224992A1 (xx)
BE (2) BE826776R (xx)
CA (1) CA1060004A (xx)
DE (2) DE2560551C2 (xx)
DK (1) DK106375A (xx)
ES (1) ES435689A2 (xx)
FR (1) FR2264552B1 (xx)
GB (1) GB1482736A (xx)
NL (1) NL7503214A (xx)
SE (1) SE7502995L (xx)
YU (2) YU42137B (xx)
ZA (1) ZA751662B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
PL347268A1 (en) * 1998-10-16 2002-03-25 Schering Corp Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
US6277830B1 (en) 1998-10-16 2001-08-21 Schering Corporation 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
EP1282632A1 (en) 2000-04-20 2003-02-12 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
JPWO2009028575A1 (ja) 2007-08-27 2010-12-02 国立大学法人名古屋大学 血液凝固第vii因子プロモーターの活性化剤及びその利用
EP2201953A4 (en) 2007-08-27 2011-08-03 Univ Nagoya Nat Univ Corp USE OF RIBAVIRIN IN BLOOD COAGULATION DISORDER
CN111205344B (zh) * 2020-01-14 2023-03-14 华东理工大学 一种用于甲醇溶剂识别的纯有机磷光小分子材料及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides

Also Published As

Publication number Publication date
FR2264552A2 (xx) 1975-10-17
YU43291B (en) 1989-06-30
NL7503214A (nl) 1975-09-22
GB1482736A (en) 1977-08-10
YU65775A (en) 1983-01-21
JPS50154253A (xx) 1975-12-12
FR2264552B1 (xx) 1980-12-19
DE2511828C2 (xx) 1991-01-17
YU42137B (en) 1988-06-30
ZA751662B (en) 1976-02-25
DK106375A (xx) 1975-09-19
DE2511828A1 (de) 1975-10-02
AR224992A1 (es) 1982-02-15
ES435689A2 (es) 1977-10-16
AU7914575A (en) 1976-09-23
YU9287A (en) 1988-04-30
BE826776R (fr) 1975-07-16
CA1060004A (en) 1979-08-07
DE2560551C2 (xx) 1989-02-23
BE903674Q (fr) 1986-05-20

Similar Documents

Publication Publication Date Title
FR2260091A1 (xx)
HU169662B (xx)
CH576801A5 (xx)
CH131675A4 (xx)
AU481825A (xx)
BE830261A (xx)
BG20144A1 (xx)
BG20518A1 (xx)
BG20665A1 (xx)
BG20679A1 (xx)
BG20710A1 (xx)
BG20838A1 (xx)
BG20915A1 (xx)
BG20984A1 (xx)
BG21047A1 (xx)
BG21118A1 (xx)
BG21565A1 (xx)
BG21697A1 (xx)
BG21826A1 (xx)
CH577406A5 (xx)
BG22268A1 (xx)
BG22303A1 (xx)
BG23232A1 (xx)
BG26368A3 (xx)
BG26410A1 (xx)